Signant collaborated with a renowned clinical research group to develop a more efficient Neurostatus-Expanded Disability Status Scale (EDSS) instrument. The goal was to have this electronic instrument capture clinical trial data on a web platform.

This instrument can accelerate drug development by:

• Streamlining the data collection process
• Improving data quality
• Enabling quicker analyses

For a comprehensive list of benefits, read our Neurostatus-EDSS brochure.